PH9682A - 1,2,3,4-tetrahydro-4-phenyl-isoquinoline derivatives and pharmaceutical composition containing same - Google Patents

1,2,3,4-tetrahydro-4-phenyl-isoquinoline derivatives and pharmaceutical composition containing same

Info

Publication number
PH9682A
PH9682A PH12087*UA PH12087A PH9682A PH 9682 A PH9682 A PH 9682A PH 12087 A PH12087 A PH 12087A PH 9682 A PH9682 A PH 9682A
Authority
PH
Philippines
Prior art keywords
tetrahydro
phenyl
pharmaceutical composition
composition containing
containing same
Prior art date
Application number
PH12087*UA
Other languages
English (en)
Inventor
A Rheiner
Original Assignee
A Rheiner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Rheiner filed Critical A Rheiner
Publication of PH9682A publication Critical patent/PH9682A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH12087*UA 1970-01-06 1971-01-07 1,2,3,4-tetrahydro-4-phenyl-isoquinoline derivatives and pharmaceutical composition containing same PH9682A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH10370A CH527194A (de) 1970-01-06 1970-01-06 Verfahren zur Herstellung von Isochinolin-Derivaten

Publications (1)

Publication Number Publication Date
PH9682A true PH9682A (en) 1976-02-10

Family

ID=4179328

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12087*UA PH9682A (en) 1970-01-06 1971-01-07 1,2,3,4-tetrahydro-4-phenyl-isoquinoline derivatives and pharmaceutical composition containing same

Country Status (19)

Country Link
JP (1) JPS5515476B1 (sv)
AT (1) AT303041B (sv)
BE (1) BE761219A (sv)
CA (1) CA999866A (sv)
CH (2) CH527194A (sv)
DE (1) DE2062001C2 (sv)
DK (1) DK125021B (sv)
ES (1) ES387016A1 (sv)
FI (1) FI49503C (sv)
FR (1) FR2081412B1 (sv)
GB (1) GB1335261A (sv)
IE (1) IE34859B1 (sv)
IL (1) IL35916A (sv)
NL (1) NL171444C (sv)
NO (1) NO135315C (sv)
PH (1) PH9682A (sv)
SE (3) SE368401B (sv)
YU (1) YU33660B (sv)
ZA (1) ZA708590B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA844402B (en) * 1983-06-23 1986-01-29 Mcneil Pharmaceutical Hexahydropyrrolo(2,1-a)isoquinoline derivatives
US4595688A (en) * 1983-06-23 1986-06-17 Mcneilab, Inc. Hexahydropyrrolo[2,1-a]isoquinoline derivatives and antidepressant use thereof
US4719216A (en) * 1983-06-23 1988-01-12 Mcneilab, Inc. Hexahydropyrrolo(2,1-A)isoquinoline derivatives as antidepressants
GB2271566A (en) * 1992-10-14 1994-04-20 Merck & Co Inc HIV integrase inhibitors
EP1246806B1 (en) 1999-11-03 2008-02-27 AMR Technology, Inc. Arly- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
US7163949B1 (en) * 1999-11-03 2007-01-16 Amr Technology, Inc. 4-phenyl substituted tetrahydroisoquinolines and use thereof
CN100436420C (zh) * 1999-11-03 2008-11-26 Amr科技公司 4-苯基取代的四氢异喹啉及其用于制备药物的用途
EP1113007A1 (en) 1999-12-24 2001-07-04 Pfizer Inc. Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
EP1299393A2 (en) 2000-07-11 2003-04-09 Bristol-Myers Squibb Pharma Company 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
MX2007000428A (es) 2004-07-15 2008-03-05 Amr Technology Inc Tetrahidroisoquinolinas sustituidas con arilo y heteroarilo y uso de las mismas para bloquear la captacion de norepinefrina, dopamina y serotonina.
DK1899334T3 (da) * 2005-06-17 2008-11-24 Janssen Pharmaceutica Nv Naphthyridinforbindelser
CN101495184A (zh) 2005-07-15 2009-07-29 Amr科技公司 芳基和杂芳基取代的四氢苯并氮杂及其在阻断去甲肾上腺素多巴胺和血清素的重摄取中的应用
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
AR071997A1 (es) 2008-06-04 2010-07-28 Bristol Myers Squibb Co Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
PE20120373A1 (es) 2009-05-12 2012-05-17 Albany Molecular Res Inc 7-([1,2,4]triazolo[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina
WO2010132487A1 (en) 2009-05-12 2010-11-18 Bristol-Myers Squibb Company CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
AU2010247849B2 (en) 2009-05-12 2015-11-19 Albany Molecular Research, Inc. Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670694B2 (de) * 1966-05-05 1976-07-22 Hoechst Ag, 6000 Frankfurt Verfahren zur herstellung von tetrahydroisochinolinen

Also Published As

Publication number Publication date
IE34859L (en) 1971-07-06
NL171444B (nl) 1982-11-01
AT303041B (de) 1972-11-10
IE34859B1 (en) 1975-09-03
DK125021B (da) 1972-12-18
IL35916A0 (en) 1971-02-25
YU33660B (en) 1977-12-31
IL35916A (en) 1973-11-28
FI49503C (sv) 1975-07-10
SE368401B (sv) 1974-07-01
NO135315B (sv) 1976-12-13
JPS5515476B1 (sv) 1980-04-23
ES387016A1 (es) 1976-05-01
CA999866A (en) 1976-11-16
FI49503B (sv) 1975-04-01
FR2081412A1 (sv) 1971-12-03
NL7018956A (sv) 1971-07-08
SE386672B (sv) 1976-08-16
GB1335261A (en) 1973-10-24
CH527194A (de) 1972-08-31
SE399879B (sv) 1978-03-06
BE761219A (fr) 1971-07-05
NO135315C (sv) 1977-03-23
DE2062001A1 (de) 1971-07-15
CH538477A (de) 1973-06-30
ZA708590B (en) 1971-09-29
NL171444C (nl) 1983-04-05
YU1971A (en) 1977-06-30
DE2062001C2 (de) 1986-10-16
FR2081412B1 (sv) 1974-04-12

Similar Documents

Publication Publication Date Title
IL38364A0 (en) 8-azapurin-6-one derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL36320A0 (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
PH9682A (en) 1,2,3,4-tetrahydro-4-phenyl-isoquinoline derivatives and pharmaceutical composition containing same
IL37984A0 (en) 2,4-diamino-5-benzylpyrimidine derivatives,their preparation and pharmaceutical compositions containing them
IL37813A0 (en) Phenylalamine derivatives,their manufacture and pharmaceutical compositions containing them
IL36398A0 (en) 3,4-dihydroisoquinoline derivatives,processes for their preparation and pharmaceutical compositions containing the same
IL36211A0 (en) N(6)-aralkyl-adenosine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
IL36345A (en) Benzhydryl-piperazine derivatives,their preparation and pharmaceutical compositions containing them
IL38593A (en) Substituted 2-arylamino-imidazoline-(2)derivatives,their preparation and pharmaceutical compositions containing them
IL36559A (en) N-substituted-4-hydroxy-4-benzoyl-3-phenyl-piperidine derivatives,their preparation and pharmaceutical compositions containing them
IL37146A (en) Indenopyrrole derivatives,their preparation and pharmaceutical compositions containing them
IL36549A0 (en) Substituted imidazolines-(2),their preparation and pharmaceutical compositions containing them
IL36160A (en) 7-azido-5-phenyl-dihydro-benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
IL37234A0 (en) Thiazole derivatives,their manufacture and pharmaceutical compositions containing them
IL37900A0 (en) Thiazolone-(2)derivatives,their preparation,and pharmaceutical compositions containing them
IL37888A (en) 3-phenyl-2-alkoxycarbonylaminophenyl-6(7)alkoxycarbonylamino-4-quinazolone derivatives,their production and pharmaceutical compositions containing them
IL37231A0 (en) Bornanamine derivatives,their preparation and pharmaceutical compositions containing them
IL37621A (en) Benzocycloheptathiophene derivatives,their preparation and pharmaceutical compositions containing them
IL37702A0 (en) Phenethylamide derivatives,their manufacture and pharmaceutical compositions containing them
IL36536A0 (en) Substituted 1,2,4,5-tetrahydro-(3h)-3-benzazepines,their preparation and pharmaceutical compositions containing them
IL36397A (en) N-vinyl-quinolones,processes for the preparation thereof and pharmaceutical compositions containing the same
IL35976A0 (en) Cardenolide-rhamnosides,their preparation and pharmaceutical compositions containing them
IL36352A (en) 20-imino-14 alpha,17 alpha-ethylidenedioxy-19-nor pregnatetraene derivatives,their preparation and pharmaceutical compositions containing them
IL36499A0 (en) 1,2,4-oxadiazoline derivatives,their preparation and pharmaceutical compositions containing them
IL38310A0 (en) Benzopyranobenzopyran derivatives,their preparation and pharmaceutical compositions containing them